Nukkleus (NUKK) files 8-K on November 25, 2025 press release

Nukkleus Inc. (NUKK) filed a current report to note that on November 25, 2025 it issued a press release, which is attached as Exhibit 99.1 and incorporated by reference.

Rhea-AI Filing Summary

Nukkleus Inc. (NUKK) filed a current report to note that on November 25, 2025 it issued a press release, which is attached as Exhibit 99.1 and incorporated by reference. The filing does not describe the contents of the press release, only that it has been formally released and furnished to the market.

The report also reiterates that Nukkleus’s common stock trades on Nasdaq under the symbol NUKK, and its publicly listed warrants, each exercisable for one share of common stock at $92.00 per share, trade under the symbol NUKKW.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Nukkleus Inc. (NUKK) report in its November 25, 2025 Form 8-K?

Nukkleus Inc. reported that it issued a press release dated November 25, 2025, which is attached as Exhibit 99.1 and incorporated by reference.

What exhibits are included with Nukkleus (NUKK) November 25, 2025 Form 8-K?

The filing includes Exhibit 99.1, a press release dated November 25, 2025, and Exhibit 104, the cover page interactive data file embedded in the Inline XBRL document.

On which exchange is Nukkleus (NUKK) common stock listed and under what symbol?

Nukkleus Inc.’s common stock, par value $0.0001 per share, is listed on The Nasdaq Stock Market LLC under the symbol NUKK.

What are the terms of Nukkleus (NUKKW) warrants mentioned in the Form 8-K?

The warrants trade on Nasdaq under the symbol NUKKW, with each warrant exercisable for one share of Nukkleus common stock at an exercise price of $92.00 per share.

Who signed the November 25, 2025 Form 8-K for Nukkleus Inc.?

The report was signed on behalf of Nukkleus Inc. by Menachem Shalom, who is identified as the company’s Chief Executive Officer.

Does the Nukkleus (NUKK) Form 8-K describe the contents of the press release?

The Form 8-K states that Nukkleus issued a press release on November 25, 2025 and attaches it as Exhibit 99.1, but does not describe its contents in the body of the report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/25/2025 - 05:28 PM EST Learn about SEC filing dates

false 0001787518 0001787518 2025-11-25 2025-11-25 0001787518 NUKK:CommonStock0.0001ParValuePerShareMember 2025-11-25 2025-11-25 0001787518 NUKK:WarrantsEachWarrantExercisableForOneShareOfCommonStockFor92.00PerShareMember 2025-11-25 2025-11-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or Section 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 25, 2025

NUKKLEUS INC.
(Exact name of registrant as specified in its charter)

Delaware		001-39341		38-3912845
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(IRS Employer Identification Number)

575 Fifth Avenue, 14^th Floor

New York, New York 10017

(Address of principal executive offices)

212-791-4663

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value per share		NUKK		The Nasdaq Stock Market LLC
Warrants, each warrant exercisable for one Share of Common Stock for $92.00 per share		NUKKW		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 8.01 Other Events.

On November 25, 2025, Nukkleus Inc. issued a press release, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit 99.1		Press Release dated November 25, 2025
Exhibit 104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	NUKKLEUS INC.
Date: November 25, 2025	By:	/s/ Menachem Shalom
	Name:	Menachem Shalom
	Title:	Chief Executive Officer

2